Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT
Cancer Cell International volume 23, Article number: 216 (2023)
Retraction Note: Cancer Cell Int (2019) 19:284 https://doi.org/10.1186/s12935-019-1007-7
The Editors-in-Chief have retracted this article. Concerns were raised regarding a number of figures, specifically:
The Editors-in-Chief therefore no longer have confidence in the results and conclusions this article.
The authors agree with this retraction.
Miao Y, Lu M, Yan Q, Li S, Feng Y. Inhibition of proliferation, migration, and invasion by knockdown of pyruvate kinase-M2 (PKM2) in ovarian cancer SKOV3 and OVCAR3 cells. Oncol Res. 2016;24(6):463–75. https://doi.org/10.3727/096504016X14685034103671.
Liang T, Ye X, Liu Y, Qiu X, Li Z, Tian B, Yan D. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin. Exp Mol Med. 2018;50(12):1–12. https://doi.org/10.1038/s12276-018-0184-0.
Zhang S, Wang Y, Chen S, Li J. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Biomed Pharmacother. 2018;106:1396–403. https://doi.org/10.1016/j.biopha.2018.07.104.
Shi J, Wang Q, Li H, Huang Q. Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes Mol. BioSyst. 2016;12:1445–56. https://doi.org/10.1039/C5MB00722D.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wang, B., Wang, G., Wang, Q. et al. Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT. Cancer Cell Int 23, 216 (2023). https://doi.org/10.1186/s12935-023-03017-2